chr12-85280410-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000316824.4(ALX1):āc.149T>Cā(p.Val50Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,613,226 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Synonymous variant affecting the same amino acid position (i.e. V50V) has been classified as Likely benign.
Frequency
Consequence
ENST00000316824.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALX1 | NM_006982.3 | c.149T>C | p.Val50Ala | missense_variant | 1/4 | ENST00000316824.4 | NP_008913.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALX1 | ENST00000316824.4 | c.149T>C | p.Val50Ala | missense_variant | 1/4 | 1 | NM_006982.3 | ENSP00000315417 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152136Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251060Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135842
GnomAD4 exome AF: 0.0000246 AC: 36AN: 1461090Hom.: 0 Cov.: 32 AF XY: 0.0000206 AC XY: 15AN XY: 726826
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152136Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74306
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 08, 2022 | Variant summary: ALX1 c.149T>C (p.Val50Ala) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4.4e-05 in 251060 control chromosomes (gnomAD). This frequency is not significantly higher than expected for a pathogenic variant in ALX1 causing Frontonasal Dysplasia, Severe Microphthalmia, Severe Facial Clefting Syndrome (4.4e-05 vs ND), allowing no conclusion about variant significance. To our knowledge, no occurrence of c.149T>C in individuals affected with Frontonasal Dysplasia, Severe Microphthalmia, Severe Facial Clefting Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 20, 2024 | The c.149T>C (p.V50A) alteration is located in exon 1 (coding exon 1) of the ALX1 gene. This alteration results from a T to C substitution at nucleotide position 149, causing the valine (V) at amino acid position 50 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at